Commonwealth Numbered Regulations

1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 4

SCHEDULE 4
Regulation 5
AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH
(PHARMACEUTICAL BENEFITS) REGULATIONS
1. After item 15 insert the following items:
      "15A Bromocriptine Mesylate, Tablets 2.5 mg     With the written

authority of the
Permanent Head-
Pathological
hyperprolactinaemia
where appropriate
surgery or radiotherapy
are not indicated or
have already been used
with incomplete
resolution
     15B Bromocriptine Mesylate, Capsules 10 mg .     With the written

authority of the
Permanent Head-
Acromegaly, prior to
surgery or radiotherapy
or where surgery or
radiotherapy is
inappropriate".
2. Omit item 37, substitute the following item:
     "Cholestyramine  . . . . . . . . . . . . . .     With the written

authority of the
Permanent Head-
Bile salt malabsorption
associated with ileal
resection or proven
ileal disease
Pruritus associated
with partial biliary
obstruction not
responding toother
therapy
Hypercholesterolaemia".
3. Omit item 39A, substitute the following item:
     "39A Clofibrate Capsules, B.P. . . . . . . .     With the written

authority of the
Permanent Head-
Hypertriglyceridaemia
Hypercholesterolaemia
4. After item 43 insert the following item:

"43A Codeine Phosphate, B.P. with
Paracetamol, B.P. Tablets 8 mg-500 mg . . . . . .     For pensioners only".

5. Omit item 44, substitute the following item:
     "44 Colestipol Hydrochloride . . . . . . . .     With the written

authority of the
Permanent Head-
Hypercholesterolaemia".
6. Omit item 109.
7. After item 110 insert the following item:
     "110A Mianserin Hydrochloride  . . . . . . .     With the written

authority of the
Permanent Head-
Depressive illness in
persons with
cardiovascular disease".
8. Omit item 156, substitute the following item:
     "156 (1) Sodium Valproate Syrup                  Epilepsy".


(2) Sodium Valproate Tablet 200 mg
9. After item 156 insert the following item:

"156A Sodium Valproate Tablet 500 mg
(enteric coated)  . . . . . . . . . . . . . . . .     With the written

authority of the
Permanent Head-
Epilepsy in patients
requiring more than 1 g
of sodium valproate
daily".
10. Omit item 160, substitute the following item:
     "160 Sulindac  . . . . . . . . . . . . . . .     With the written

authority of the
Permanent Head-
Chronic
rheumatoid arthritis not
responding to other
non-steroidal
anti-inflammatory drugs
(disregarding
phenylbutazone)
Chronic osteoarthritis
not responding to other
non-steroidal
anti-inflammatory drugs
(disregarding
phenylbutazone)".
11. After 176 insert the following item:
     "176A Trimipramine . . . . . . . . . . . . .     With the written

authority of the
Permanent Head-
Endogenous depression
where there is an
inadequate response to
not less than 100 mg of
trimipramine daily".
12. After 177 insert the following item

"177A Tri-potassium Di-citrato Bismuthate
Complex . . . . . . . . . . . . . . . . . . . . .     With the

written authority of the
Permanent Head-
Duodenal ulcer confirmed
by radiology, endoscopy
or surgery
Gastric ulcer confirmed
by radiology, endoscopy,
or surgery".